CYTARABINE INJECTION
Google image searchProduct monograph
Active ingredient
cytarabine, 100 MG/ML
DIN: 02515296
Dosage form(s): SOLUTION
Route(s) of administration: INTRATHECAL, INTRAVENOUS, SUBCUTANEOUS
Description: SINGLE-USE VIAL
Schedule: Prescription
Company: STERIMAX INC
Date: 21-APR-2022
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01B — ANTIMETABOLITES (ATC, ATC/DDD)
- L01BC — Pyrimidine analogues (ATC, ATC/DDD)
- L01BC01 — CYTARABINE (ATC/DDD)
Reference brand drug: Cytosar
Pharmaceutical standard: MFR
